First Defense

First Defense
Immune Formula

First Defense

4 Fluid Ounce (118.5ml) Liquid Formula

First Defense is a unique ChildLife® formula. We have researched and hand-selected herbs and minerals known for their direct and effective immune response properties.* First Defense is completely safe for children of all ages and can be used either short or long term to increase natural defense responses.*

For stimulating natural immune responses and defending the body. Use daily at the recommended dosages. Use with ChildLife® Echinacea and ChildLife® Vitamin C for extra immune support.*

ChildLife® uses only the highest quality ingredients.

This formula is gluten free, casein free and alcohol free. It contains no milk, eggs, soy, wheat, yeast or corn. No artificial colorings, flavorings or sweeteners.

Suggested Use:
For infants 6 mos–1 yr:
1/2 teaspoon 3x daily
For children 1-12 yrs:
1 teaspoon 3x daily
• Shake well before use.
• Store in a cool dry place away from sunlight.
• Give directly or mix with your child’s favorite drink.

First Defense facts

Other Ingredients
Purified Water, Glycerin, Citric Acid, Grapefruit Seed Extract, Stevia, Potassium Sorbate, Gum Arabic.


*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

References:

Olive Leaf extract

Micol V., Caturla N., et al. “The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV).” Antiviral Res. 2005 Jun;66(2-3):129-36.

Walker, M, MD, “Olive Leaf: Nature’s Most Powerful Antibiotic”, 1998.

Walker M, “Olive Leaf Extract: The New Oral Treatment to Counteract Most Types of Pathological Organisms.” Explorel. Vol. 7, No 4. 1996.

Bisignano G. et al. “On the In-vitro Antimicrobial Activity of Olerupein and Hydroxytrysol.” J. Pharm. Pharmacol. 1999. 55:pp. 971-74.

St John’s Wort

“Extracts from St. John’s Wort and their anti-microbial activity.” P. Res, 2004.

Hudson,JB et al, “Antiviral Activites of Hypericum.” Antiviral Res 15:101-12, 1991.

De Smet PA. “Herbal remedies. St. John’s Wort” New England Journal of Medicine. 2002;347(25):2046–2056.

Blumenthal M, Goldberg A, Brinckman J, eds. “Herbal Medicine: Expanded Commission on St. John’s Wort” E Monographs. Newton, MA: Lippincott Williams & Wilkins; 2000:359–366.

Colloidal Silver

Natural Medicines Comprehensive Database. Colloidal silver. Natural Medicines Comprehensive Database Web site. Accessed on December 11, 2006.

Canty,LM, Baranowski,Z, “Colloidal Silver: The Antibiotic Alternative” The Colloid Research Foundation,1994.

Powell, J, “Our mightiest germ fighter,” Science Digest, 59-60, 1978.

Farber, MP., “The Silver Micro Bullet.” Prof Physicians Health Serv, Inc. Houston, 1995.

A.B.G. Lansdown, “Silver I: its antibacterial properties and mechanism of action.” Journal of Wound Care, Vol. 11, Iss. 4, 01 Apr 2002, pp 125 – 130.

Larch Arabinogalactan

Currier NL, Lejtenyi D, Miller SC. “Effect over time of in-vivo administration of the polysaccharide arabinogalactan on immune and hemopoietic cell lineages in murine spleen and bone marrow.” Phytomedicine. 2003 Mar;10(2-3):145-53.

“Larch arabinogalactan.” Altern Med Rev. 2000 Oct;5(5):463-6.

Kelly GS. “Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide.: Altern Med Rev. 1999 Apr;4(2):96-103.

Hauer J, Anderer FA. “Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis.” Cancer Immunol Immunother. 1993;36(4):237-44.

Zinc gluconate

Hulisz D. “Efficacy of zinc against common cold viruses: an overview.” J Am Pharm Assoc. 2004 Sep-Oct;44(5):594-603.

Sazawal S, Jalla S, Mazumder S, Sinha A, Black RE, Bhan MK. “Effect of zinc supplementation on cell-mediated immunity and lymphocyte subsets in preschool children.” Indian Pediatr. 1997 Jul;34(7):589-97.

Mossad SB, Macknin ML, Medendorp SV, Mason P. “Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study.” Ann Intern Med. 1996 Jul 15;125(2):81-8.

Vitamin C

H . Hemilä “Vitamin C supplementation and common cold symptoms: factors affecting the magnitude of the benefit.”Med Hypothesis. 1999. Vol. 52 , Iss. 2 , Pg. 171 – 178.

Douglas RM, Hemilä H, Chalker E, Treacy B. “Vitamin C for preventing and treating the common cold.” Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000980.

Sasazuki S, Sasaki S, Tsubono Y, Okubo S, Hayashi M, Tsugane S. “Effect of vitamin C on common cold: randomized controlled trial.” Eur J Clin Nutr. 2006 Jan;60(1):9-17.

Hemilä H. “Vitamin C supplementation and respiratory infections: a systematic review.” Mil Med. 2004 Nov;169(11):920-5.

Hemilä H, Louhiala P. “Vitamin C for preventing and treating pneumonia.” Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005532.